作为抗微生物和抗生素增强剂的合剂的结构-活性关系研究 合剂作为抗微生物和抗生素增强剂
Melissa M Cadelis1,2, Tim Liu1, Kenneth Sue1
1School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Pharmaceuticals (Basel, Switzerland)
|June 28, 2023
概括
研究人员探索了海洋天然产品,以对抗抗生素耐药性. 他们开发了新型化合物,增强现有的抗生素对抗抗性细菌,如Pseudomonas aeruginosa,提供新的治疗策略.
科学领域:
- 海洋天然产品化学 海洋天然产品化学
- 药品化学 药品化学 是一个
- 发现抗微生物药物发现.
背景情况:
- 抗生素耐药性是一个关键的全球健康挑战.
- 需要新的策略来克服耐药性,包括抗生素增强剂.
- 海洋天然产品是新型抗菌化合物的有希望的来源.
研究的目的:
- 为了合成和评估新型的内基-精子胺类同类物.
- 研究这些类似物对抗微生物和抗生素增强性能的结构-活性关系.
- 为了确定有效对抗耐药细菌的无毒化合物.
主要方法:
- 综合一个带有印基基-精子胺衍生物库的库,其中包括印替代和聚胺链长度的变化.
- 评估抗微生物活性对抗阳性和阴性细菌.
- 细胞毒性和血液溶解活性的评估.
- 对抗生素增强效应的测试与多西环素和米诺环素结合对抗*Pseudomonas aeruginosa*.
主要成果:
- 两种7甲基替代类型 (23b和23c) 显示出对格拉姆阳性细菌的强烈活性,没有细胞毒性或血液溶解.
- 一种5-甲基替代类型 (19a) 作为对多克西环素和米诺环素的无毒增强剂对抗P. aeruginosa.
- 结构-活性关系研究揭示了抗微生物与抗生素增强活性的独特分子特征.
结论:
- 来自海洋的印基-精子类类似物代表了开发新抗微生物药物和抗生素增强剂的宝贵支架.
- 特定的结构修改可以产生具有强大的抗微生物活性或显著抗生素增强作用的化合物.
- 这些发现支持对海洋天然产品的持续探索,以寻找抗生素耐药性的新解决方案.
相关概念视频
01:27Combined Effects of Drugs: Synergism
4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.1K
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.0K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.0K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
608
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
608
01:28Antimicrobial Effectiveness
98
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
98
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K